PATENT CLAIM ANALYSIS

Application Number: 16030430
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-10
Patent Classification: ["514", "003800"]

Abstract:
A multipartite peptide that inhibits release of exosomes in a cell, comprising an N-terminal end and a C-terminal end and comprising at least one secretion modifying region (SMR) peptide from HIV-1 Nef and at least one Clusterin (Clu)-binding peptide (Clu-BP). Pharmaceutical compositions comprising these peptides alone or in synergistic combinations with other active agents in methods for treating cancers and/or infectious diseases are further provided herein.

Claim (Index 20):
The method of  claim 19 , wherein the subject is infected with HIV-1 or HIV-2.

Metadata:
- Claim Count in Document: 46.0
- Percentile: 95.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15383454', '12783829', '14015438', '13693507', '13621597']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8134568604683124
- 35 USC 102 Novelty (BERT): 0.6239142921456996
- Combined Prediction Score: 0.7945026036360512
- Mean Citation Score: 448.13848800000005
- Max Citation Score: 747.8006
- Similarity Product: 495.1039474199534

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test